Novel antimicrobial peptide–modified azithromycin-loaded liposomes against methicillin-resistant Staphylococcus aureus

References

• World Health OrganizationAntimicrobial Resistance: Global Report on SurveillanceWorld Health Organization2014 Available from: http://www.who.int/drugresistance/documents/surveillancereport/en/Accessed August 31, 2016
   Google Scholar
• BuickSJoffeAMTaylorGConlyJA consensus development conference model for establishing health policy for surveillance and screening of antimicrobial-resistant organismsClin Infect Dis20156071095110125542896
   PubMedGoogle Scholar
• LaiC-CLeeKXiaoYHigh burden of antimicrobial drug resistance in AsiaJ Glob Antimicrob Resist20142314114727873720
   PubMedGoogle Scholar
• ChangH-HCohenTGradYHHanageWPO’BrienTFLipsitchMOrigin and proliferation of multiple-drug resistance in bacterial pathogensMicrobiol Mol Biol Rev201579110111625652543
   PubMed Web of Science ®Google Scholar
• BoucherHWTalbotGHBenjaminDK10×20 Progress – development of new drugs active against gram-negative bacilli: an update from the Infectious Diseases Society of AmericaClin Infect Dis201356121685169423599308
   PubMed Web of Science ®Google Scholar
• RoemerTBooneCSystems-level antimicrobial drug and drug synergy discoveryNat Chem Biol20139422223123508188
   PubMed Web of Science ®Google Scholar
• SpellbergBPowersJHBrassEPMillerLGEdwardsJETrends in antimicrobial drug development: implications for the futureClin Infect Dis20043891279128615127341
   PubMed Web of Science ®Google Scholar
• AkovaMDaikosGTzouvelekisLCarmeliYInterventional strategies and current clinical experience with carbapenemase-producing Gram-negative bacteriaClin Microbiol Infect201218543944822507111
   PubMed Web of Science ®Google Scholar
• GiamarellouHGalaniLBaziakaFKaraiskosIEffectiveness of a double-carbapenem regimen for infections in humans due to carbapenemase-producing pandrug-resistant Klebsiella pneumoniaeAntimicrob agents chemother20135752388239023439635
   PubMed Web of Science ®Google Scholar
• PierenMTiggesMAdjuvant strategies for potentiation of antibiotics to overcome antimicrobial resistanceCurr Opin Pharmacol201212555155522835931
   PubMed Web of Science ®Google Scholar
• EjimLFarhaMAFalconerSBCombinations of antibiotics and nonantibiotic drugs enhance antimicrobial efficacyNat Chem Biol20117634835021516114
   PubMed Web of Science ®Google Scholar
• FarhaMABrownEDDiscovery of antibiotic adjuvantsNat Biotechnol201331212012223392510
   PubMedGoogle Scholar
• BushKCourvalinPDantasGTackling antibiotic resistanceNat Rev Microbiol201191289489622048738
   PubMed Web of Science ®Google Scholar
• ImperiFMassaiFPillaiCRNew life for an old drug: the anthelmintic drug niclosamide inhibits Pseudomonas aeruginosa quorum sensingAntimicrob Agents Chemother2013572996100523254430
   PubMed Web of Science ®Google Scholar
• WuFMengGHeJWuYWuFGuZAntibiotic-loaded chitosan hydrogel with superior dual functions: antibacterial efficacy and osteoblastic cell responsesACS Appl Mater Interfaces2014613100051001324938653
   PubMed Web of Science ®Google Scholar
• ZhaoYJiangXMultiple strategies to activate gold nanoparticles as antibioticsNanoscale20135188340835023893008
   PubMed Web of Science ®Google Scholar
• ZhouCWangMZouKChenJZhuYDuJAntibacterial polypeptide-grafted chitosan-based nanocapsules as an “armed” carrier of anticancer and antiepileptic drugsACS Macro Letters201321110211025
   Google Scholar
• LiCZhangXHuangXWangXLiaoGChenZPreparation and characterization of flexible nanoliposomes loaded with daptomycin, a novel antibiotic, for topical skin therapyInt J Nanomedicine201381285129223569376
   PubMed Web of Science ®Google Scholar
• HancockRESahlH-GAntimicrobial and host-defense peptides as new anti-infective therapeutic strategiesNat Biotechnol200624121551155717160061
   PubMed Web of Science ®Google Scholar
• HancockREScottMGThe role of antimicrobial peptides in animal defensesProc Natl Acad Sci U S A200097168856886110922046
   PubMed Web of Science ®Google Scholar
• MorrisCJBeckKFoxMAUlaetoDClarkGCGumbletonMPegylation of antimicrobial peptides maintains the active peptide conformation, model membrane interactions, and antimicrobial activity while improving lung tissue biocompatibility following airway deliveryAntimicrob Agents Chemother20125663298330822430978
   PubMedGoogle Scholar
• WuXWangZLiXIn vitro and in vivo activities of antimicrobial peptides developed using an amino acid-based activity prediction methodAntimicrob Agents Chemother20145895342534924982064
   PubMed Web of Science ®Google Scholar
• ScottMGDullaghanEMookherjeeNAn anti-infective peptide that selectively modulates the innate immune responseNat Biotechnol200725446547217384586
   PubMed Web of Science ®Google Scholar
• BraffMHHawkinsMADi NardoAStructure-function relationships among human cathelicidin peptides: dissociation of antimicrobial properties from host immunostimulatory activitiesJ Immunol200517474271427815778390
   PubMed Web of Science ®Google Scholar
• KarlssonAJPomerantzWCWeisblumBGellmanSHPalecekSPAntifungal activity from 14-helical β-peptidesJ Am Chem Soc200612839126301263117002340
   PubMed Web of Science ®Google Scholar
• ZasloffMAntimicrobial peptides of multicellular organismsNature2002415687038939511807545
   PubMed Web of Science ®Google Scholar
• NagaokaIHirotaSNiyonsabaFAugmentation of the lipopoly-saccharide-neutralizing activities of human cathelicidin CAP18/LL-37-derived antimicrobial peptides by replacement with hydrophobic and cationic amino acid residuesClin Diagn Lab Immunol20029597298212204946
   PubMedGoogle Scholar
• VignoniMde Alwis WeerasekeraHSimpsonMJLL37 peptide@silver nanoparticles: combining the best of the two worlds for skin infection controlNanoscale20146115725572824789474
   PubMedGoogle Scholar
• HancockRELehrerRCationic peptides: a new source of antibioticsTrends Biotechnol199816282889487736
   PubMed Web of Science ®Google Scholar
• TravisSYapLMHawkeyCRDP58 is a novel and potentially effective oral therapy for ulcerative colitisInflamm Bowel Dis200511871371916043985
   PubMedGoogle Scholar
• ChenWLYuanZQLiuYLiposomes coated with N-trimethyl chitosan to improve the absorption of harmine in vivo and in vitroInt J Nanomedicine20161132526855571
   PubMed Web of Science ®Google Scholar
• TatedaKIshiiYMatsumotoTDirect evidence for antipseudomonal activity of macrolides: exposure-dependent bactericidal activity and inhibition of protein synthesis by erythromycin, clarithromycin, and azithromycinAntimicrob Agents Chemother19964010227122758891128
   PubMedGoogle Scholar
• AzhdarzadehMLotfipourFZakeri-MilaniPMohammadiGValizadehHAnti-bacterial performance of azithromycin nanoparticles as colloidal drug delivery system against different gram-negative and gram-positive bacteriaAdv Pharmal Bull20122117
   PubMedGoogle Scholar
• Zakeri-MilaniPGhanbarzadehSLotfi poorFMilaniMValizadehHPharmacokinetic study of two macrolide antibiotic oral suspensions using an optimized bioassay procedureJ Bioequiv Bioavailab20102111115
   Google Scholar
• SugieMAsakuraEZhaoYLPossible involvement of the drug transporters P glycoprotein and multidrug resistance-associated protein Mrp2 in disposition of azithromycinAntimicrob Agents Chemother200448380981414982769
   PubMedGoogle Scholar
• HeZYuYZhangYGene delivery with active targeting to ovarian cancer cells mediated by folate receptor αJ Biomed Nanotechnol20139583384423802413
   PubMedGoogle Scholar
• GouMMenKShiHCurcumin-loaded biodegradable polymeric micelles for colon cancer therapy in vitro and in vivoNanoscale2011341558156721283869
   PubMed Web of Science ®Google Scholar
• BruzzeseFDi GennaroEAvalloneASynergistic antitumor activity of epidermal growth factor receptor tyrosine kinase inhibitor gefitinib and IFN-α in head and neck cancer cells in vitro and in vivoClin Cancer Res200612261762516428508
   PubMedGoogle Scholar
• PfafflMWA new mathematical model for relative quantification in real-time RT-PCRNucleic Acids Res2001299e45e4511328886
   PubMed Web of Science ®Google Scholar
• GaoHHeQThe interaction of nanoparticles with plasma proteins and the consequent influence on nanoparticles behaviorExpert Opin Drug Deliv201411340942024397260
   PubMed Web of Science ®Google Scholar
• LiuYMeiLYuQMultifunctional tandem peptide modified paclitaxel-loaded liposomes for the treatment of vasculogenic mimicry and cancer stem cells in malignant gliomaACS Appl Mater Interfaces2015730167921680126173814
   PubMed Web of Science ®Google Scholar
• ZhangQZhangXChenTA safe and efficient hepatocyte-selective carrier system based on myristoylated preS1/21-47 domain of hepatitis B virusNanoscale20157209298931025945919
   PubMedGoogle Scholar
• TsujiMTakemaMMiwaHShimadaJKuwaharaSIn vivo antibacterial activity of S-3578, a new broad-spectrum cephalosporin: methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa experimental infection modelsAntimicrob Agents Chemother20034782507251212878512
   PubMedGoogle Scholar
• WieczorekMJenssenHKindrachukJStructural studies of a peptide with immune modulating and direct antimicrobial activityChem Biol201017997098020851346
   PubMedGoogle Scholar
• GoldbergDWinfieldDDiagnostic accuracy of serum enzyme assays for myocardial infarction in a general hospital populationBr Heart J19723465975040259
   PubMedGoogle Scholar
• OzerJSChettyRKennaGEnhancing the utility of alanine aminotransferase as a reference standard biomarker for drug-induced liver injuryRegul Toxicol Pharmacol201056323724619903504
   PubMed Web of Science ®Google Scholar
• XinHShaXJiangXZhangWChenLFangXAnti-glioblastoma efficacy and safety of paclitaxel-loading angiopep-conjugated dual targeting PEG-PCL nanoparticlesBiomaterials201233328167817622889488
   PubMed Web of Science ®Google Scholar
• LiS-DHuangLPharmacokinetics and biodistribution of nanoparticlesMol Pharm20085449650418611037
   PubMed Web of Science ®Google Scholar
• KimBYRutkaJTChanWCNanomedicineN Engl J Med2010363252434244321158659
   PubMed Web of Science ®Google Scholar
• GongCYangTYangXCarrier-free nanoassemblies of a novel oxazolidinone compound FYL-67 display antimicrobial activity on methicillin-resistant Staphylococcus aureusNanoscale20135127528323160636
   PubMedGoogle Scholar
• BowdishDMDavidsonDJLauYELeeKScottMGHancockREImpact of LL-37 on anti-infective immunityJ Leuko Biol200577445145915569695
   PubMed Web of Science ®Google Scholar
• CederlundAGudmundssonGHAgerberthBAntimicrobial peptides important in innate immunityFEBS J2011278203942395121848912
   PubMed Web of Science ®Google Scholar
• LinLNonejuiePMunguiaJAzithromycin synergizes with cationic antimicrobial peptides to exert bactericidal and therapeutic activity against highly multidrug-resistant Gram-negative bacterial pathogensEBioMedicine201527688696
   Google Scholar
• MatijašićMKosVMNujićKFluorescently labeled macrolides as a tool for monitoring cellular and tissue distribution of azithromycinPharmacol Res201266433234222749903
   PubMedGoogle Scholar
• SochackiKABarnsKJBuckiRWeisshaarJCReal-time attack on single Escherichia coli cells by the human antimicrobial peptide LL-37Proc Natl Acad Sci U S A201110816E77E8121464330
   PubMed Web of Science ®Google Scholar